Gland Pharma Clarifies Director Remuneration Approval Process

Gland Pharma clarifies the approval process for Ms. Naina Lal Kidwai's reappointment as an Independent Director.
The company states that a special resolution will be sought each year her remuneration exceeds 50% of total non-executive director pay.
This clarification follows a postal ballot notice dated April 09, 2026, for the period from FY 2026-27 to FY 2030-31.